España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Qiagen
QGEN
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$41.10
0.52
1.28%
At Close: -
$41.03
-0.07
-0.17%
After Hours: 9:26 AM EDT
15 minutes delayed
Get Report
Watch
Qiagen (QGEN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Qiagen (NYSE:QGEN) Stock
Qiagen Stock (NYSE: QGEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 28, 2024
QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test
Zacks
Thursday, June 27, 2024
Wolfe Research Upgrades Qiagen to Outperform,...
Benzinga Newsdesk
Monday, June 24, 2024
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
Vandana Singh
Friday, June 21, 2024
CORRECTION : JP Morgan Maintains Overweight o...
Benzinga Newsdesk
Thursday, June 20, 2024
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Tuesday, June 18, 2024
JP Morgan Maintains Overweight on Qiagen, Rai...
Benzinga Newsdesk
Monday, June 17, 2024
Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches
Vandana Singh
Qiagen CEO Says Other Smaller Low-margin Prod...
Benzinga Newsdesk
QIAGEN Plans To Achieve At Least 31% CER Adju...
Benzinga Newsdesk
QIAGEN To Announce At Its Capital Markets Day...
Benzinga Newsdesk
Tuesday, June 11, 2024
QIAGEN Launches 35 New Digital PCR Microbial ...
Benzinga Newsdesk
Thursday, June 06, 2024
QIAGEN Reaffirms Q2 Outlook, Updates FY24 Adj...
Benzinga Newsdesk
QIAGEN To Discontinue NeuMoDx Integrated PCR ...
Benzinga Newsdesk
Wednesday, June 05, 2024
Qiagen Launches Digital PCR Assay Design Tool...
Benzinga Newsdesk
Monday, June 03, 2024
QIAGEN Launches Rapid GI Infection Test in th...
Benzinga Newsdesk
Thursday, May 30, 2024
QIAGEN And Myriad Genetics To Develop Globall...
Benzinga Newsdesk
Qualigen Therapeutics Received Nasdaq Notice ...
Benzinga Newsdesk
Wednesday, May 29, 2024
QIAGEN Launches QIAseq Multimodal DNA/RNA Lib...
Benzinga Newsdesk
Tuesday, May 14, 2024
Qiagen Secures European IVDR Certification Fo...
Benzinga Newsdesk
Monday, May 13, 2024
FDA Clears QIAGEN's Qiastat-Dx Respiratory Sy...
Benzinga Newsdesk
Tuesday, May 07, 2024
Qiagen Partners With FBI To Develop Digital P...
Benzinga Newsdesk
Monday, May 06, 2024
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
Shanthi Rexaline
Thursday, May 02, 2024
QIAGEN Enhances Bioinformatics Workflows With...
Benzinga Newsdesk
Wednesday, May 01, 2024
Stifel Maintains Hold on Qiagen, Lowers Price...
Benzinga Newsdesk
Monday, April 29, 2024
QIAGEN Reaffirms FY24 Adj. EPS $2.10 Vs $2.11...
Benzinga Newsdesk
Qiagen Q1 2024 Adj EPS $0.46 Beats $0.44 Esti...
Benzinga Newsdesk
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
Piero Cingari
US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition
Shanthi Rexaline
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Shanthi Rexaline
Wednesday, April 24, 2024
QIAGEN Expands Tuberculosis Portfolio With Ne...
Benzinga Newsdesk
Monday, March 18, 2024
QIAGEN Partners With International Panel Phys...
Benzinga Newsdesk
Tuesday, February 27, 2024
QIAGEN Unveils AI-Derived Biomedical Knowledg...
Benzinga Newsdesk
Thursday, February 08, 2024
JP Morgan Maintains Overweight on Qiagen, Rai...
Benzinga Newsdesk
Citigroup Maintains Buy on Qiagen, Lowers Pri...
Benzinga Newsdesk
Tuesday, February 06, 2024
QIAGEN Sees FY24 EPS $2.10 CER Vs $2.20 CER E...
Benzinga Newsdesk
Qiagen Q4 EPS $0.55 Beats $0.53 Estimate, Sal...
Benzinga Newsdesk
Watching Qiagen N.V.; Traders Circulating Sto...
Benzinga Newsdesk
Earnings Scheduled For February 6, 2024
Benzinga Insights
Monday, February 05, 2024
Earnings Preview: Qiagen
Benzinga Insights
Thursday, January 25, 2024
QIAGEN Announces Partnership With Penn State ...
Benzinga Newsdesk
Wednesday, January 17, 2024
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
Vandana Singh
Monday, January 08, 2024
QIAGEN Bags FDA Clearance of NeuMoDx CT/NG As...
Benzinga Newsdesk
Sunday, January 07, 2024
QIAGEN To Return ~$300M To Shareholders Through A Synthetic Share Repurchase
Charles Gross
Thursday, January 04, 2024
QIAGEN Announces Plan To Increase Investments...
Benzinga Newsdesk
Wednesday, January 03, 2024
Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects
Lekha Gupta
QIAGEN Bolsters Middle East Presence, Launche...
Benzinga Newsdesk
Wednesday, December 20, 2023
JP Morgan Maintains Overweight on Qiagen, Rai...
Benzinga Newsdesk
Tuesday, December 19, 2023
Wells Fargo Initiates Coverage On Qiagen with...
Benzinga Newsdesk
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On Qiagen w...
Benzinga Newsdesk
Thursday, December 07, 2023
Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock
Vandana Singh
Show More